Show simple item record

dc.contributor.authorSchults, Jessica A
dc.contributor.authorRickard, Claire M
dc.contributor.authorKleidon, Tricia
dc.contributor.authorHughes, Rebecca
dc.contributor.authorMacfarlane, Fiona
dc.contributor.authorHung, Jacky
dc.contributor.authorUllman, Amanda J
dc.date.accessioned2019-06-26T06:51:10Z
dc.date.available2019-06-26T06:51:10Z
dc.date.issued2019
dc.identifier.issn1545-102X
dc.identifier.doi10.1111/wvn.12339
dc.identifier.urihttp://hdl.handle.net/10072/384643
dc.description.abstractBackground Internationally, there is a lack of comparative vascular access (VA) data for pediatric clinicians and organizations to benchmark outcomes, evaluate quality initiatives, and improve practice. A VA registry is needed to address these knowledge and data capture gaps. Objectives To determine the range and heterogeneity of VA outcome measures or quality indicators reported in randomized controlled trials (RCTs) and clinical registries, to inform development of a homogeneous, reliable, minimum dataset for a pediatric VA registry. Methods Scoping review framework. A systematic search for RCTs reporting VA outcomes in pediatrics and neonates was undertaken in the Cochrane library, EMBASE, CINAHL, PubMed, MEDLINE, and EBSCO using a medical subject headings and key words related to VA and pediatrics. We included RCTs of children (0–18 years) reporting any VA outcome. We identified clinical registries reporting VA data in children (0–18) through web‐based searches using key words related to VA and clinical or quality registries. Additional registries were identified through peer consultation. The frequency and scope of outcome measures and quality indicators were extracted from trials and registries and evaluated. Results From 93 RCTs included, 214 different VA measures were reported, reflecting 14 outcome domains. The most commonly reported outcome domains were insertion (44 RCTs; 47%), noninfectious complications (33 RCTs; 35%), and infectious complications (30 RCTs; 32%). Of the 22 registries identified, VA‐associated infection was the main quality indicator routinely collected (12 registries; 55%). Outcomes such as mechanical complications and patient‐reported outcomes were infrequently collected. Linking Evidence to Action Vascular access outcomes reported in pediatric and neonatal RCTs are highly heterogeneous. Internationally, clinical registries currently collect minimal VA data with the exception of infection outcomes. A core dataset of reliable, relevant measures to children and clinicians for VA device quality is needed. This will enable a VA registry that facilitates inter‐institutional and international benchmarking.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofpagefrom51
dc.relation.ispartofpageto59
dc.relation.ispartofissue1
dc.relation.ispartofjournalWORLDVIEWS ON EVIDENCE-BASED NURSING
dc.relation.ispartofvolume16
dc.subject.fieldofresearchNursing
dc.subject.fieldofresearchcode4205
dc.titleBuilding a Global, Pediatric Vascular Access Registry: A Scoping Review of Trial Outcomes and Quality Indicators to Inform Evidence-Based Practice
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.rights.copyright© 2018 Worldviews on Evidence-Based Nursing. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
gro.hasfulltextFull Text
gro.griffith.authorSchults, Jessica
gro.griffith.authorHughes, Rebecca


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record